Stockscreener 앱 받기
0.5488
0.80%
-0.0044
시간 외 거래:
.55
0.0012
+0.22%
Nuwellis Inc 주식(NUWE)의 최신 뉴스
uniQure shares plunge 37% after new trial data shows reduced benefit for Huntington's drug AMT-130 - Pluang
Warrant cap keeps Nuwellis (NUWE) investor under 5% ownership - Stock Titan
Nuwellis adds EHR connectivity to Aquadex platform - scanx.trade
Nuwellis Q2FY26 Results: Gross margin expands to 76%, cash runway extends - scanx.trade
Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins - marketscreener.com
Cash could last into Q3 2027 after Nuwellis shifted production to an outside manufacturer - Stock Titan
Nuwellis, Inc. Announces First Quarter 2026 F - moomoo.com
Nuwellis, Inc. SEC Filing (Aug 27, 2026) - Stock Titan
NUWE Stock Slides As Nuwellis Strikes New Pediatric Deals - timothysykes.com
Nuwellis posts updated investor presentation highlighting Aquadex growth, 20% H1 revenue rise - tradingview.com
Nuwellis (NUWE) Expands Pediatric Reach With AtriAmp Deal - timothysykes.com
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Nigeria
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com Canada
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com India
Nuwellis enters co-promotion deal for cardiac monitoring device By Investing.com - Investing.com UK
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical - The Manila Times
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingAdvance Decline Line - vinanet.vn
Nuwellis (NUWE) Momentum: Posts a 4.27% Loss to $1.12; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Latest ReadingOn Balance Volume - dars.gov.et
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotSuperTrend - dars.gov.et
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotVolume Climax - dars.gov.et
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotDouble Bottom - vinanet.vn
Nuwellis (NUWE) Technicals: Slides 1.68% to $1.17 on the Day; Technical Setup: the $1.11 to $1.23 Range Remains in Focus under the Current SnapshotEarnings Miss Risk - dars.gov.et
Nuwellis Inc (NASDAQ: NUWE) Share Price, NUWE Stock News, NUWE Share Price & Updates - Kalkine
Armistice Capital (NUWE) trims Nuwellis ownership to a 4.99% disclosed stake - Stock Titan
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base Expands - GuruFocus
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ... - Yahoo Finance UK
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis Posts 14% Revenue Jump in Q2 2026, Misses on EPS - AlphaStreet
Nuwellis Reports Q2 2026: Revenue $2.0M, Gross Margin 76%, Net Loss $4.8M - TradingView
Nuwellis, Inc. (NASDAQ: NUWE) lifts Q2 2026 revenue and margin but stays unprofitable - Stock Titan
Nuwellis (NASDAQ: NUWE) boosts revenue, flags going concern and Nasdaq risks - Stock Titan
Nuwellis study shows epoprostenol safe for pediatric Aquadex therapy - scanx.trade
Nuwellis Q2 Results: Revenue Up 14% YoY, Gross Margin Expands To 76% - scanx.trade
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com Nigeria
NUWE: Q2 revenue up 14% year-over-year, gross margin at 76%, and net loss reduced to $4.8 million - TradingView
Earnings call transcript: Nuwellis posts higher revenue in Q2 2026 as loss narrows - Investing.com
Transcript : Nuwellis, Inc., Q2 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
Nuwellis Q2 2026 Earnings Call Transcript - Benzinga
Q2 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - marketscreener.com
BRIEF-Nuwellis Q2 EPS USD -26.64 - TradingView
Press Release: Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin - Moomoo
NUWE Q2'26 Earnings: EPS estimate is (23.80) USD - TradingView
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Nuwellis Announces Digital Transformation Program for Aquadex SmartFlow System with Philips Capsule Integration - Quiver Quantitative
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface - The Manila Times
Nuwellis Announces Digital Transformation of the Aquadex Smartflow System with Ehr Connectivity and Enhanced User Interface - marketscreener.com
Nuwellis partners with Philips Capsule to connect Aquadex platform to hospital EHR systems - Bitget
Q&A: Building the next generation of cardiorenal care: An interview with Nuwellis - Digital Journal
7.22%
자본화:
|
볼륨(24시간):